Can We Delay Alzheimer's Symptoms Before They Begin? Inside the PrevenTRON Trial
Aug 31, 2026 - 00:08:31
Radio and PodcastLive Radio & PodcastsHealth
Advancing MOGAD Care
No Label: Michael Levy, MD, PhD No Label: Peter V. Sguigna, MD What do the latest METEOROID trial results mean for neurologists treating myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)? Michael Le...
Related Episodes
Continue listening to more episodes from NeuroFrontiers.
Subcutaneous Lecanemab for Early Alzheimer Disease: Evidence, Safety, and Patient Selection
Aug 20, 2026 - 00:11:37
Multidisciplinary Coordination in TK2d Diagnosis and Management
Jun 24, 2026 - 00:11:15
Navigating Stem Cell Therapy Conversations in MS
Jun 8, 2026 - 00:04:45
Cognitive Screening in MS: Practical Strategies and Modern Approaches
May 28, 2026 - 00:03:30
Identifying the Respiratory Manifestations of TK2d: The Pulmonologist’s Role
May 14, 2026 - 00:14:45
Recognizing TK2d: Key Clinical Signs and Diagnostic Protocols
May 14, 2026 - 00:13:30